26-Aug-2026
Cabot’s Top Executive Makes a Bold Move With Fresh Stock Sale
TipRanks (Wed, 26-Aug 10:01 PM ET)
Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029
Globe Newswire (Wed, 12-Aug 5:35 PM ET)
Cabot Corporation Reports Third Quarter Fiscal Year 2026 Results
Globe Newswire (Mon, 3-Aug 4:31 PM ET)
Cabot Corporation Announces Planned Leadership Transition
Globe Newswire (Thu, 30-Jul 8:30 AM ET)
Cabot Corporation Board Declares Dividend
Globe Newswire (Fri, 10-Jul 4:03 PM ET)
Cabot Corporation to Announce Third Quarter Fiscal 2026 Operating Results
Globe Newswire (Thu, 9-Jul 4:01 PM ET)
Globe Newswire (Tue, 23-Jun 9:00 AM ET)
Cabot Corporation Earns EcoVadis Platinum Rating for Sixth Consecutive Year
Globe Newswire (Thu, 18-Jun 8:30 AM ET)
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
Cabot trades on the NYSE stock market under the symbol CBT.
As of August 26, 2026, CBT stock price climbed to $84.58 with 221,652 million shares trading.
CBT has a beta of 0.56, meaning it tends to be less sensitive to market movements. CBT has a correlation of 0.05 to the broad based SPY ETF.
CBT has a market cap of $4.37 billion. This is considered a Mid Cap stock.
Last quarter Cabot reported $982 million in Revenue and $1.67 earnings per share. This beat revenue expectation by $57 million and exceeded earnings estimates by $.02.
In the last 3 years, CBT traded as high as $117.46 and as low as $58.33.
The top ETF exchange traded funds that CBT belongs to (by Net Assets): AVUV, IJH, VTI, IWM, VB.
CBT has underperformed the market in the last year with a price return of +5.9% while the SPY ETF gained +19.9%. CBT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +0.4% and -2.0%, respectively, while the SPY returned +2.3% and -0.8%, respectively.
CBT support price is $81.80 and resistance is $85.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBT shares will trade within this expected range on the day.